JD Health International Inc
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. Th… Read more
JD Health International Inc (JDHIY) - Net Assets
Latest net assets as of June 2025: $57.98 Billion USD
Based on the latest financial reports, JD Health International Inc (JDHIY) has net assets worth $57.98 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($78.46 Billion) and total liabilities ($20.48 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $57.98 Billion |
| % of Total Assets | 73.89% |
| Annual Growth Rate | 88.11% |
| 5-Year Change | 40.74% |
| 10-Year Change | N/A |
| Growth Volatility | 63.88 |
JD Health International Inc - Net Assets Trend (2017–2024)
This chart illustrates how JD Health International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for JD Health International Inc (2017–2024)
The table below shows the annual net assets of JD Health International Inc from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $55.24 Billion | +11.89% |
| 2023-12-31 | $49.37 Billion | +10.24% |
| 2022-12-31 | $44.78 Billion | +12.37% |
| 2021-12-31 | $39.85 Billion | +1.54% |
| 2020-12-31 | $39.25 Billion | +8650.91% |
| 2019-12-31 | $-459.03 Million | -161.27% |
| 2018-12-31 | $749.22 Million | +13.07% |
| 2017-12-31 | $662.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to JD Health International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1317009500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $11.00K | 0.00% |
| Other Comprehensive Income | $8.54 Billion | 15.46% |
| Other Components | $59.92 Billion | 108.48% |
| Total Equity | $55.23 Billion | 100.00% |
JD Health International Inc Competitors by Market Cap
The table below lists competitors of JD Health International Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cavco Industries Inc
NASDAQ:CVCO
|
$3.88 Billion |
|
PT. Chandra Asri Petrochemical Tbk
PINK:PTPIF
|
$3.88 Billion |
|
Compal Electronics Inc
TW:2324
|
$3.88 Billion |
|
Nexans S.A
PINK:NXPRF
|
$3.88 Billion |
|
Maximus Inc
NYSE:MMS
|
$3.88 Billion |
|
Yunnan Chuangxin New Material Co Ltd
SHE:002812
|
$3.88 Billion |
|
Yue Yuen Industrial Holdings
PINK:YUEIY
|
$3.87 Billion |
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
$3.87 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JD Health International Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 49,355,752,000 to 55,231,156,000, a change of 5,875,404,000 (11.9%).
- Net income of 4,161,844,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 305,692,000.
- Other factors increased equity by 1,407,868,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.16 Billion | +7.54% |
| Other Comprehensive Income | $305.69 Million | +0.55% |
| Other Changes | $1.41 Billion | +2.55% |
| Total Change | $- | 11.90% |
Book Value vs Market Value Analysis
This analysis compares JD Health International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.22x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 17.98x to 0.22x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.21 | $3.81 | x |
| 2018-12-31 | $0.24 | $3.81 | x |
| 2019-12-31 | $-0.14 | $3.81 | x |
| 2020-12-31 | $12.33 | $3.81 | x |
| 2021-12-31 | $12.88 | $3.81 | x |
| 2022-12-31 | $14.24 | $3.81 | x |
| 2023-12-31 | $15.60 | $3.81 | x |
| 2024-12-31 | $17.50 | $3.81 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JD Health International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.16%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 1.29x
- Recent ROE (7.54%) is above the historical average (2.72%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 26.94% | 3.22% | 6.09x | 1.38x | $112.27 Million |
| 2018 | 28.69% | 2.63% | 6.91x | 1.58x | $140.00 Million |
| 2019 | 0.00% | -8.96% | 1.25x | 0.00x | $-925.90 Million |
| 2020 | -43.91% | -88.92% | 0.44x | 1.12x | $-21.16 Billion |
| 2021 | -2.69% | -3.50% | 0.64x | 1.20x | $-5.06 Billion |
| 2022 | 0.85% | 0.81% | 0.76x | 1.37x | $-4.10 Billion |
| 2023 | 4.34% | 4.00% | 0.83x | 1.30x | $-2.79 Billion |
| 2024 | 7.54% | 7.16% | 0.82x | 1.29x | $-1.36 Billion |
Industry Comparison
This section compares JD Health International Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JD Health International Inc (JDHIY) | $57.98 Billion | 26.94% | 0.35x | $3.88 Billion |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |